Conversation with The Cancer Letter

COVID-19 & Cancer

Early in 2020, we watched with growing alarm as early warnings of the virulence of SARS-CoV-2 started pouring in from Wuhan, and later, from Lombardy. At The Cancer Letter, we quickly decided to chart a course for intensive coverage of the pandemic as it reached our shores—oncologists are well-poised to take the lead in shaping research on COVID-19, and exposure mitigation strategies for high-risk patients. This coverage is collected here.
Cancer care in the COVID-19 world: Adjusting to a new reality
COVID-19 & CancerFreeTrials & Tribulations

Cancer care in the COVID-19 world: Adjusting to a new reality

Oncology practices face difficult challenges while delivering care in the middle of COVID-19, as they care for patients who are at higher risk for this potentially deadly disease. While there is still much to learn about how COVID-19 impacts various patient populations, early studies of COVID-19 patients with a history of cancer provide some insight.
By Marcus Neubauer
Stephen Nimer: Cancer patients are coming in for treatment, Florida’s COVID-19 spike notwithstanding
Conversation with The Cancer LetterCOVID-19 & CancerFree

Stephen Nimer: Cancer patients are coming in for treatment, Florida’s COVID-19 spike notwithstanding

“Our chemotherapy and radiation therapy volumes have been very robust. Probably because of the NCI designation, we are seeing significantly more patients than last year,” Stephen D. Nimer, director of Sylvester Comprehensive Cancer Center, said to The Cancer Letter. “Compared to last year, we seem to be up about 15%. We’ve been growing by about 8% to 9% for quite some years. This year is even more.”
By Paul Goldberg